General Announcement::Notice of 42nd Annual General Meeting of the Company

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PH US$200M4.5%210802 - XS1456577334 - 4N4B
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
04-Sep-2020 22:30:45
Status
New
Announcement Sub Title
Notice of 42nd Annual General Meeting of the Company
Announcement Reference
SG200904OTHRM7I3
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
Company Secretary & Compliance Officer
Effective Date and Time of the event
04/09/2020 00:00:00
Description (Please provide a detailed description of the event in the box below)
Notice of 42nd Annual General Meeting of the Company for FY 2019-20 as required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Attachments

SGX_AGM_NOTICE_04092020.pdf
Total size =490K